THERACRYF PLC
TCF | IL
Overview
Corporate Details
- ISIN(s):
- GB00BMVN2C70 (+2 more)
- LEI:
- 213800NO3E6TSTQO8K20
- Country:
- United Kingdom
- Address:
- SUITE 24G13 - BLOCK 24, SK10 4TG NETHER ALDERLEY
- Website:
- https://theracryf.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
TheraCryf plc develops innovative therapeutics for oncology and behavioral brain disorders. Its strategy is to partner with larger pharma companies after generating compelling data. Key assets include SFX-01 and novel compounds targeting brain health.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-04 16:27 |
Major Shareholding Notification
Holding(s) in Company
|
English | 23.3 KB | |
| 2025-07-17 08:00 |
Regulatory News Service
Manufacturing Scale Up of Lead Ox-1 Programme
|
English | 14.1 KB | |
| 2025-07-09 16:07 |
Post-Annual General Meeting Information
Result of AGM
|
English | 12.3 KB | |
| 2025-06-16 17:10 |
Report Publication Announcement
Notice of AGM
|
English | 13.0 KB | |
| 2025-06-10 13:32 |
Investor Presentation
Ox-1 Investor Presentation
|
English | 11.6 KB | |
| 2025-06-03 08:00 |
Earnings Release
Final results for year to 31 March 2025
|
English | 235.9 KB | |
| 2025-05-23 08:14 |
Report Publication Announcement
Notice of Results and Ox-1 presentation
|
English | 12.5 KB | |
| 2025-05-22 13:43 |
Major Shareholding Notification
Holding(s) in Company
|
English | 52.1 KB | |
| 2025-05-16 14:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 23.2 KB | |
| 2025-03-26 08:00 |
Investor Presentation
Investor webinar
|
English | 16.2 KB | |
| 2025-03-19 13:10 |
Major Shareholding Notification
Holding(s) in Company
|
English | 23.3 KB | |
| 2025-03-17 15:17 |
Major Shareholding Notification
Holding(s) in Company
|
English | 52.1 KB | |
| 2025-03-17 08:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 52.3 KB | |
| 2025-03-13 08:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 24.0 KB | |
| 2025-03-12 15:03 |
Major Shareholding Notification
Holding(s) in Company
|
English | 23.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Rapid Nutrition | United Kingdom | RPNRF | |
|
RaQualia Pharma Inc. | Japan | 4579 | |
|
Recordati Industria Chimica e Farmaceutica | Italy | REC | |
|
Rekah Pharmaceutical Prod Ltd. | Israel | REKA | |
|
RELIEF Therapeutics Holding AG | Switzerland | RLF | |
|
Renascience Inc. | Japan | 4889 | |
|
Replek AD | North Macedonia | REPL | |
| RIBOMIC Inc. | Japan | 4591 | ||
|
Roche Holding AG | Switzerland | RO | |
|
ROHTO PHARMACEUTICAL CO.,LTD. | Japan | 4527 |